HEAD AND NECK (HNSCC)
Clinical trials for HEAD AND NECK (HNSCC) explained in plain language.
Never miss a new study
Get alerted when new HEAD AND NECK (HNSCC) trials appear
Sign up with your email to follow new studies for HEAD AND NECK (HNSCC), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill takes aim at Hard-to-Treat cancers
Disease control Recruiting nowThis trial tests an experimental drug called CP-383 in people with advanced solid tumors (like lung, colon, or pancreatic cancer) that have not responded to standard treatments. The drug is taken daily by mouth and works by blocking a process cancer cells need to grow. The study …
Matched conditions: HEAD AND NECK (HNSCC)
Phase: PHASE1, PHASE2 • Sponsor: Tasca Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New cancer drug GI-108 enters human trials for advanced tumors
Disease control Recruiting nowThis study tests a new drug called GI-108 in people with advanced or metastatic solid tumors, including lung, head and neck, pancreatic, and kidney cancers. The drug is designed to boost the immune system's ability to fight cancer. The trial will first find the safest dose, then …
Matched conditions: HEAD AND NECK (HNSCC)
Phase: PHASE1, PHASE2 • Sponsor: GI Innovation, Inc. • Aim: Disease control
Last updated Jun 26, 2026 17:00 UTC
-
Blood test may reveal hidden tumor secrets in head and neck cancer
Knowledge-focused Recruiting nowThis study looks at whether a simple blood test can give the same information about a tumor's biology as testing the tumor tissue itself. Researchers will collect blood samples from 300 adults with HPV-negative head and neck cancer before and after standard treatment. They will c…
Matched conditions: HEAD AND NECK (HNSCC)
Sponsor: Fondazione IRCCS Istituto Nazionale dei Tumori, Milano • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:04 UTC